TriMix Laboratories Announces Major Product Enhancement
CHERRY HILL, N.J., Oct. 29 /PRNewswire/ -- TriMix Laboratories LLC today announced a major enhancement to their flagship product TriMix-gel(TM). TriMix-gel(TM) uses the ED gel(TM) (pat. pend.) applicator system. The applicator has been fitted with an adapter to make the use of TriMix-gel(TM) even easier for the patient. The adapter will be included for shipment to patients immediately.
The new adapter is featured on the website http://www.trimixgel.com. A video there includes a demonstration of an actual patient applying the medicine. TriMix Laboratories President T.J. Harkins says, "The innovative nature of the TriMix-gel(TM) applicator makes it hard to describe in a small sound bite. This video is an important tool in helping ED patients understand how valuable TriMix-gel(TM) can be for them."
TriMix-gel(TM) has been used by doctors as an alternative erectile dysfunction (ED) treatment. Doctors prescribe TriMix-gel(TM) for patients who have failed on Viagra, Levitra or Cialis type tablets or who cannot tolerate their side effects. Trimix ingredients have been tested and widely prescribed for many years for improvement of sexual health.
TriMix-gel(TM) contains active ingredients which are classified as medicine and are listed in the US Pharmacopoeia. Therefore, a patient would need a prescription from his physician to obtain TriMix-gel(TM). For an order form, visit http://www.trimixgel.com and click the prescription form. The patient gives the form to the doctor. The doctor faxes the prescription to the pharmacy at 877-387-4649 and the pharmacy ships the medicine directly to the patient.
Typically, the trimix liquid for injection version of the compound would have to be refrigerated and then self injected with a needle at time of use. But the compound in gel form, called TriMix-gel(TM), allows the patient to carry the medicine at room temperature. More importantly, an ED patient will not have to use a needle to self inject before sexual intercourse.
Recently, clinical trials were performed on TriMix-gel(TM). All the test patients were men who failed on Viagra, Levitra or Cialis tablets. These patients were given TriMix-gel(TM). All the test patients received some degree of positive effect from TriMix-gel(TM) in the form of tumescence (enlargement). It was determined that 40% of the test patients achieved a result sufficient for sexual intercourse over Viagra, Levitra or Cialis tablets.
The trial results were published in the Journal of Urology Supplement, J. Urol. 179 (4): 431, 2008. For more information, visit http://www.trimixgel.com and click "Drug Studies."
TriMix Laboratories President T.J. Harkins said, "Our test patients were very impressed with the 'ease of use.' We are happy our new adapter is so well received."
TriMix Laboratories LLC is a medical research and marketing firm
specializing in the urological subspecialty of erectile dysfunction. The
information contained herein is general in nature and is intended for use
only as an informational aid. It does not cover all possible uses, actions,
precautions, side effects, or interactions of the products shown, nor is
the information intended as medical advice or diagnosis for individual
health problems. TriMix-gel(TM) has not been evaluated by the Food and Drug
Administration ("FDA"). TriMix-gel(TM) is not made under GMP requirements.
It is compounded in a licensed compounding pharmacy for the use of an
individual patient who has been prescribed TriMix-gel(TM) by a licensed
physician. It is not intended for making an evaluation as to the risks and
benefits. Before taking any action, consult your Doctor.
Contact: T.J. Harkins
Cherry Hill, NJ
|SOURCE TriMix Laboratories LLC|
Copyright©2008 PR Newswire.
All rights reserved